Take Action to Stop the Release of Genetically Modified Mosquitoes in Florida Keys!

imgres[Comment: Please consider sending comments. What’s really amazing is that, as investigative reporter Jon Rappoport https://jonrappoport.wordpress.com/category/zika/  and others have shown, scientists have NOT clearly linked the Zika virus to microcephaly (small head disease). Of the originally reported 4000 cases of small head disease in Brazil, it turned out only to be about 400. And of those 400 – only around 17 have the virus. But – this country, on no evidence, devotes a billion plus dollars to research a vaccine and Florida declares a health emergency!
We are in the twilight zone.
Once the GM mosquitoes get loose, there’s no telling what will happen. And please don’t forget that such GM mosquitoes WERE released in Brazil about 18 months ago.
Stay tuned to this site for links to scientific arguments opposing the release of GM mosquitoes.]

Genetically modified mosquitoes clear key hurdle for Key West test


FDA, in preliminary study, finds no significant environmental threat from mosquito release

Tentative OK will be revisited after 30 days of public comment

The GMO mosquitoes touted as a potential tool in Zika fight

Federal officials approved the release of genetically modified mosquitoes on Friday for field trials in the Florida Keys. The decision comes as the number of Zika cases transmitted by the mosquitoes rises.

By Jenny Staletovich


  • The release of genetically modified mosquitoes in the Florida Keys cleared a significant hurdle Friday when the U.S. Food and Drug Administration announced they pose no significant environmental danger.

The preliminary findings, to be published in the Federal Register, will be open for public comment for the next 30 days. But the initial federal review likely clears the way for a long-delayed field trial by British producer Oxitec in the tiny affluent neighborhood of Key Haven a mile east of Key West.

Pressure has mounted to speed up testing after the arrival of the Zika virus, which is carried by the Aedes aegypti mosquito, in the U.S. and Florida. While no cases have been contracted locally, health officials fear South Florida could face an outbreak. Oxitec’s genetically modified mosquitoes have already been released in South America, where health officials say an ongoing Zika outbreak could infect 4 million people by the end of the year. The virus is tied to a host of health problems, possibly including a spike in babies born with microcephaly in Brazil.

Oxitec CEO Hadyn Parry welcomed the move.

“The Aedes aegypti mosquito represents a significant threat to human health, and in many countries has been spreading Zika, dengue and chikungunya viruses,” he said in statement. “This mosquito is non-native to the US and difficult to control, with the best available methods only able to reduce the population by up to 50 percent, which is simply not enough.”

Since the company has already outfitted a lab in Marathon for production, the company could move quickly to start tests if local officials back them, he said in an email.

But some residents in the Keys, backed by opponents of the genetic modification industry, have fought bitterly to stop the release, mounting a petition that collected 160,000 signatures.

“People just don’t want to be guinea pigs,” said former nurse and real estate agent Mila De Mier, who started the petition.

Pitched as a safer, more affordable way of battling Oxitec’s modified male mosquitoes are engineered to produce offspring with a kill-switch, or defective gene that kills them. The offspring also bear a florescent marker gene so larvae can be identified when inspectors conduct mosquito counts and gauge the progress of the program.

De Mier, however, say no tests have linked the release of mosquitoes to a reduction in disease and argues that other methods used by the Florida Keys Mosquito Control District to combat Aedes aegypti have been successful. She also likens the tests to clinical trials and believes Oxitec ethically needs to obtain permission from residents.

“You cannot even justify a trial,” she said.

If after the public comment period the FDA approves the test, the district’s board must still approve an agreement with Oxitec, said district spokeswoman Beth Ranson. The issue is not on the board’s Tuesday meeting agenda, although she said it’s likely to come up for discussion, but not a vote.

“So there’s still a couple of steps left,” she said.

The district plans on posting the link for comments on its web site. Comments can be submitted online to the FDA or mailed to The Division of Dockets Management, HFA-305, Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852.


The federal Food and Drug Administration is accepting public comments on the draft environmental assessment for releasing genetically modified mosquitoes in the Florida Keys. The public has 30 days to comment from the date of publication in the Federal Register.

To submit comments electronically to the docket, go to www.regulations.gov and type FDA-2014-N-2235 in the search box. While comments are welcome at any time, you should submit them by the closing date to ensure FDA considers them.

To submit your comments by mail, use the following address. Be sure to include docket number FDA-2014-N-2235 on each page of your written comments.

The address: The Division of Dockets Management, HFA-305, Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s